Target intelligence / Profile preview

RN7SK pseudogene 241 (RN7SKP241)

Target
RN7SKP241
Molecular classification
Other (non-coding RNA pseudogene)
01

Overview

**RN7SK pseudogene 241 (RN7SKP241)** is a *pseudogene* related to the functional **7SK small nuclear RNA (RN7SK)** gene family. **7SK RNA** is a well-characterized non-coding RNA involved in regulating transcription elongation through inhibition of the positive transcription elongation factor P-TEFb, and is critical for transcriptional control[1][2][3]. However, the suffix "pseudogene" and designation "RN7SKP241" indicate that this is a *pseudogene*—a non-functional genomic sequence resembling the functional RN7SK gene, and does not encode a functional RNA product nor is it considered a protein-coding therapeutic target. There is no evidence in current biomedical literature or databases that RN7SK pseudogene 241 is itself a druggable target, marker, or has characterized biological or disease roles. **Note:** - This entry appears to refer to a specific pseudogene copy of the 7SK RNA gene family, not the functional RNA molecule itself. - Pseudogenes, by definition, generally do not produce functional molecules; they are not classified as receptors, enzymes, or therapeutic targets and usually lack biological, disease, or drug interaction annotations. - All functional information and molecular roles pertain to the *7SK RNA*, not the pseudogene variants. **Summary**: RN7SK pseudogene 241 is a non-functional genomic DNA element, and not a therapeutic target, receptor, or molecule with independent biological or pharmacological significance given current knowledge. If you intended the *functional 7SK RNA* ("RN7SK"), please clarify for a more specific and structured target profile[1][2][3].

Other names
RN7SKP241RNA, 7SK small nuclear pseudogene 241

Beyond the preview

Go deeper on RN7SK pseudogene 241 (RN7SKP241).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RN7SK pseudogene 241 (RN7SKP241).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call